ライフサイエンスコーパス: antibody-dependent enhancement

1 nd vice versa because of a phenomenon termed antibody-dependent enhancement.

2 erity of secondary flavivirus infections via antibody-dependent enhancement.

3 ve broad HA reactivity, yet they do not have antibody-dependent enhancement activity.

4 lusion, here we find that in the presence of Antibody Dependent Enhancement (ADE) heterogeneity can i

5 evere dengue disease focus on the process of antibody-dependent enhancement (ADE) as a primary risk f

6 p-regulated DENV infection by a mechanism of antibody-dependent enhancement (ADE) in a variety of Fc

7 investigates the complex dynamics induced by antibody-dependent enhancement (ADE) in multiserotype di

8 Antibody-dependent enhancement (ADE) is implicated in se

9 sed severity seen in secondary infections is antibody-dependent enhancement (ADE) leading to increase

10 The proposed antibody-dependent enhancement (ADE) mechanism for sever

11 tate Zika virus (ZIKV) infection through the antibody-dependent enhancement (ADE) mechanism.

12 Antibody-dependent enhancement (ADE) of dengue virus (DE

13 protection against DENV disease and prevents antibody-dependent enhancement (ADE) of disease in mice.

14 mmune serum, it has been shown in vitro that antibody-dependent enhancement (ADE) of ZIKV infection c

15 cross-reaction to ZIKV and was able to drive antibody-dependent enhancement (ADE) of ZIKV infection.

16 ble of both cross-neutralization, as well as antibody-dependent enhancement (ADE) of ZIKV infection.

17 Moreover, antibody-dependent enhancement (ADE) was not observed ag

18 Antibody-dependent enhancement (ADE), a phenomenon in wh

19 Antibody-dependent enhancement (ADE), a process best des

20 e virus (DENV) infections is associated with antibody-dependent enhancement (ADE), and it was recentl

21 This phenomenon is referred to as antibody-dependent enhancement (ADE).

22 eutralization potency, enhanced infection by antibody-dependent enhancement (ADE).

23 e-infection, mainly because of the effect of antibody-dependent enhancement (ADE).

24 -glycoprotein (g)D and anti-gK antibodies on antibody-dependent enhancement (ADE).

25 tate infection through a phenomenon known as antibody-dependent enhancement (ADE).

26 ersistent infection, by Fc-receptor-mediated antibody-dependent enhancement (ADE).

27 Progression to DHF/DSS is attributed to antibody-dependent enhancement (ADE); however, because o

28 tions in flavivirus immune vaccinees such as Antibody-Dependent Enhancement (ADE, a phenomenon involv

29 kly neutralizing they also may contribute to antibody-dependent enhancement and flavi virus pathogene

30 unopathology is thought to play a part, with antibody-dependent enhancement and massive immune activa

31 nteractions, arising from cross-immunity and antibody-dependent enhancement, between related pathogen

32 ovide statistical support for the process of antibody-dependent enhancement (but not original antigen

33 Complement-mediated, antibody-dependent enhancement (C'-ADE) of HIV-1IIIB and

34 Antibody-dependent enhancement has been implicated in mo

35 human sera (PHS) and the major mediators of antibody-dependent enhancement in the presence of PHS.

36 Among the 4 serotypes of dengue virus, antibody-dependent enhancement is thought to enhance vir

37 Antibody-dependent enhancement may explain the severe di

38 ion showed significant capacity for in vitro antibody dependent enhancement of Dengue-1, 2, 3 and 4 s

39 In contrast, antibody-dependent enhancement of bacterial infection is

40 I agonist blocked both primary infection and antibody-dependent enhancement of DENV infection.

41 -gamma receptor (FcgammaR), a process termed antibody-dependent enhancement of DENV infection.

42 on in the Fc region which completely ablates antibody-dependent enhancement of DENV replication in vi

43 ted against DENV-2 by using a mouse model of antibody-dependent enhancement of infection (ADE)-induce

44 This process has been termed antibody-dependent enhancement of infection and has sign

45 zed all four serotypes of DENV, and mediated antibody-dependent enhancement of infection in Fc recept

46 Antibody-dependent enhancement of infectivity was observ

47 These results suggest that antibody-dependent enhancement of NK activity may yield

48 n in late infancy is a direct consequence of antibody-dependent enhancement of replication.

49 Although suspected, such antibody-dependent enhancement of severe disease has not

50 raction of FcgammaRI with A1H3 underlays the antibody-dependent enhancement of the cellular effects o

51 rceived wisdom, patterns generated solely by antibody-dependent enhancement or heterogeneity in virus

52 Antibody-dependent enhancement was observed in animals i